Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis

著录项

• 来源
  《Diabetes》 |2011年第2期|p.644-651|共8页
• 作者

  Roberto Conti Edoardo Mannucci Pompeo Pessotto Emanuela Tassoni Paolo Carminati Fabio Giannessi Arduino Arduini;

  展开▼
• 作者单位

  Roberto Conti,1 Edoardo Mannucci,2 Pompeo Pessotto,1 Emanuela Tassoni,3 Paolo Carminati,4'* Fabio Giannessi,1 and Arduino Arduini1From the 1 Department of Endocrinology and Metabolism, sigma-tau s.p.a, Rome, Italy, the "Diabetes Agency, Careggi Teaching Hospital, University of Florence, Florence. Italy, the 'Department of Chemical Research, sigma-tau s.p.a, Rome, Italy, and the 4Paolo Camiinati, sigma-tau s.p.a, Rome, Italy.Corresponding author: Roberto Conti, iOberto.conti@sigma-tau.it.Received 10 March 2010 and accepted 6 November 2010.DOI: 10.2337/dbl0-0346A.A. is currently affiliated wilh CoreQuesI Sagl, Bioggio, Switzerland.P.P. is currently retired.[dagger] Deceased.© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is noi altered. See http://creadvecommons.org/licenses/by -ne-nd/3.0/ for details.,;

  展开▼
• 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词